Cancer patients' use of complementary and alternative medicine in Sweden: a cross-sectional study.

Autor/Urheber	Kathrin Wode; Roger Henriksson; Lena Sharp; Anna Stoltenberg; Johanna Hök Nordberg
Institution	BMC
Titel	Cancer patients' use of complementary and alternative medicine in Sweden: a cross-sectional study.
Quelle	In: doi:10.1186/s12906-019-2452-5; 1472-6882; BMC Complementary and Alternative Medicine, Vol 19, Iss 1, Pp 1-11 (2019)(2019) PDF als Volltext kostenfreie Datei
Sprache	englisch
Dokumenttyp	online; Zeitschriftenaufsatz
DOI	10.1186/s12906-019-2452-5
Schlagwörter	Complementary and alternative medicine/utilization; Oncology; Cross-sectional studies; Cancer; Adult; Integrative oncology; Other systems of medicine
Abstract	Abstract Background Access to and advice on Complementary and Alternative Medicine (CAM) are uncommon within Swedish conventional cancer care and little is known about cancer patients' own use of CAM. The aim of this cross-sectional study was to explore Swedish cancer patients´ patterns of CAM use, their experiences and preferences. Methods Questionnaires were distributed consecutively to 1297 cancer patients at a university hospital's out-patient oncology units. The response rate was 58% (n = 755). Descriptive statistics were used to analyze the survey data. A logistic regression model was used to investigate the association between CAM use and gender, age and level of education. Open-ended responses were analyzed, using qualitative content analysis. Results Lifetime CAM use was reported by 34% (n = 256), and 26% (n = 198) used CAM after cancer diagnosis. Being female, younger and having higher education predicted CAM use. Most commonly used methods were natural products including vitamins and minerals and relaxation. Main reasons for CAM use were improvement of physical, general and emotional wellbeing and increasing the body's ability to fight cancer. Satisfaction with CAM usage was generally high. Reported adverse effects were few and mild; 54% of users spent < 50 Euro a month on CAM. One third had discussed their CAM use with cancer care providers. More than half of all participants thought that cancer care providers should be able to discuss (58%) and to consider (54%) use of CAM modalities in cancer care. Conclusions Despite limited access and advice within conventional cancer care, one fourth of Swedish cancer patients use CAM. The insufficient patient-provider dialogue diverges with most patients' wish for professional guidance in their decisions and integration of CAM modalities in conventional cancer care. Concurrent and multimodal CAM use implies challenges and possibilities for cancer care that need to be considered.
Erfasst von	BASE - Bielefeld Academic Search Engine